Prescription Required
This medicine is an anti-diabetic medicine that contains Remogliflozin and Vildagliptin. It is helpful in the management of Type 2 Diabetes Mellitus.
Please consult your doctor if you have kidney impairment or any concerns regarding this.
Please consult your doctor if you have kidney impairment or any concerns regarding this.
Avoid alcohol consumption to prevent unpleasant side effects.
Information not available, seek advice from your doctor.
There is no sufficient information available regarding the use of it during pregnancy. Please consult your doctor.
There is no sufficient information available regarding the use of it during breastfeeding. Please consult your doctor.
This medicine has been formulated by combining two antidiabetic medicines: Remogliflozin and Vildagliptin. Remogliflozin reduces blood glucose levels by inhibiting the excretion of glucose through urine. Vildagliptin reduces glucose production by the liver, by increasing insulin levels and reducing glucagon levels (glucagon hormone is responsible for maintaining blood glucose level).
Type 2 diabetes mellitus is a condition of high blood sugar level despite the production of sufficient amounts of insulin in your body. This happens because of insulin resistance, which means the cells become resistant to insulin and are not able to use it effectively. It can lead to symptoms like increased thirst, frequent urination, and fatigue.
Master in Pharmacy
Content Updated on
Saturday, 17 August, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA